Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?
May 17, 2024
Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
Via
InvestorPlace
Rally Rockets: 3 Stocks Benefitting From the Market’s Unstoppable Surge
May 17, 2024
Don't miss out on profit potential of these stocks to buy. Explore three top stocks poised to unlock gains in a surging market.
Via
InvestorPlace
Evaluating Eli Lilly and Co Against Peers In Pharmaceuticals Industry
May 17, 2024
Via
Benzinga
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
May 17, 2024
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
Via
News Direct
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
May 17, 2024
Could Amgen be the next stock to soar due to a GLP-1 drug?
Via
The Motley Fool
Is Eli Lilly's Latest Deal a Gamechanger?
May 14, 2024
Eli Lilly just took a page out of Novo Nordisk's book.
Via
The Motley Fool
1 No-Brainer Growth Stock to Buy and Hold
May 11, 2024
It's hard to bet against this high-flying stock.
Via
The Motley Fool
3 Stocks To Buy Following Positive Earnings Results
May 17, 2024
Total earnings for the S&P 500 members that have reported Q1 results are up +4.8% from the same period last year on +4.1% higher revenues. The earnings growth pace reflects an acceleration relative to...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Eli Lilly's Weekly Insulin Dose On Par With Commonly Used Daily Doses, Phase 3 Studies Show
May 16, 2024
Eli Lilly phase 3 trials reveal once-weekly insulin efsitora as a non-inferior alternative to daily basal insulins for type 2 diabetes.
Via
Benzinga
The Dividend Investor’s Playbook: 3 Stocks for Consistent Cash Flow in 2024
May 16, 2024
Dive into dividend stocks to buy, featuring Walmart's robust earnings and Eli Lilly's advances in pharmaceuticals and WMT's stock split.
Via
InvestorPlace
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
May 16, 2024
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
These 2 No-Brainer Growth Stocks Are Breaking New Ground
May 16, 2024
The future keeps getting brighter for these companies.
Via
The Motley Fool
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
Wall Street Favorites: 3 Growth Stocks With Strong Buy Ratings for May 2024
May 15, 2024
It's not too late to take a position in these growth names, each of which should see their share prices rise in the near-term.
Via
InvestorPlace
No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
May 15, 2024
Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines Agency about limited supplies. The company addresses high demand and...
Via
Benzinga
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
May 15, 2024
Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease using Lilly branding. Corrective measures include compliance with federal...
Via
Benzinga
These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now
May 15, 2024
Its latest medicines for obesity and type 2 diabetes are selling rapidly.
Via
The Motley Fool
2 Top Pharma Stocks That Just Keep Getting Better and Better
May 14, 2024
Both of these businesses are finding traction in a pair of major markets.
Via
The Motley Fool
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
May 14, 2024
The biotech behemoths stand out as compelling and exciting options for investors seeking steady long-term growth.
Via
InvestorPlace
3 Magnificent Stocks That Are Passive Income Machines
May 14, 2024
These three companies have track records that should please investors.
Via
The Motley Fool
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
May 13, 2024
Pfizer seeks to expands its reach with 'Pfizer for All,' offering direct-to-consumer medical services, including COVID treatments & telehealth.
Via
Benzinga
Exposures
COVID-19
How Viking Therapeutics Stock Could 30x
May 13, 2024
This mid-cap biopharma may one day be a titan of the industry.
Via
The Motley Fool
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
May 13, 2024
These three companies could soon be the next bargain stocks to buy as the market adjusts to their developing situations.
Via
InvestorPlace
Healthcare And Biotech Investing 101: What You Need To Know.
May 13, 2024
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
MarketBeat Week in Review – 5/6 - 5/10
May 11, 2024
Sell in May, then go away got pushed to the side this week, but the bearish sentiment could return when investors get the latest read on inflation next week.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
May 11, 2024
These pharmaceutical companies are top-notch dividend growth stocks for the future.
Via
The Motley Fool
SPDR ETF Report For Friday, May 10
May 11, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Friday, May 10.
Via
Talk Markets
Topics
ETFs
Highest And Lowest Price To Sales (P/S) Ratios
May 10, 2024
In the S&P 1500 there are just under 1,175 stocks that have positive next-year EPS estimates and trailing 12-month revenues of more than $1 billion.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Biotech Stocks to Sell in May Before They Crash & Burn
May 10, 2024
Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio.
Via
InvestorPlace
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.